$Flexion Therapeutics, Inc.(FLXN)$ EFFECT - Notice of Effectiveness Filed: 2017-07-13 AccNo: 9999999995-17-001815 Size: 1 KB 网页链接
$Flexion Therapeutics, Inc.(FLXN)$ 8-K - Current report Filed: 2017-07-10 AccNo: 0001193125-17-224815 Size: 34 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Flexion Therapeutics, Inc.(FLXN)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-06-30 AccNo: 0001193125-17-219953 Size: 503 KB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K - Current report Filed: 2017-06-23 AccNo: 0001193125-17-211774 Size: 203 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: S...
$Flexion Therapeutics(FLXN)$ 内部交易: 2017-06-16,Director,Stejbach Mark ,买入,1580普通股, $17.02
$Flexion Therapeutics(FLXN)$ 内部交易: 2017-06-05,总裁 and CEO,Clayman Michael D. ,买入,5000普通股, $17.23
$Flexion Therapeutics(FLXN)$ 内部交易: 2017-06-05,Director,COLELLA SAMUEL D ,买入,5000普通股, $17.01
$Flexion Therapeutics(FLXN)$ 8-K - Current report Filed: 2017-05-08 AccNo: 0001193125-17-161143 Size: 163 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Flexion Therapeutics(FLXN)$ 8-K - Current report Filed: 2017-05-08 AccNo: 0001193125-17-161143 Size: 163 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Flexion Therapeutics(FLXN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-05 AccNo: 0001564590-17-009078 Size: 4 MB 网页链接